Unió Europea -
danès -
EMA (European Medicines Agency)
budesonide/formoterol teva pharma b.v.
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - asthma; pulmonary disease, chronic obstructive - medicin for obstruktiv sygdomme, - budesonid / formoterol teva pharma b. indikeres kun hos voksne 18 år og ældre. asthmabudesonide/formoterol teva pharma b. er angivet i den almindelige behandling af astma, hvor anvendelsen af en kombination (inhaleret binyrebarkhormon og langtidsvirkende β2 adrenoceptor agonist) er passende:-hos patienter, der ikke er tilstrækkeligt kontrolleret med inhalerede kortikosteroider og "efter behov" inhaleret korttidsvirkende β2 adrenoceptor-agonister. eller-i patienter, der allerede er tilstrækkeligt kontrolleret på både inhaleret binyrebarkhormon og langtidsvirkende β2 adrenoceptor-agonister. copdsymptomatic behandling af patienter med kol med forceret udånding volumen i 1 sekund (fev1) .
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
oxis turbuhaler 4,5 mikrogram/dosis inhalationspulver
orifarm a/s - formoterolfumarat dihydrat - inhalationspulver - 4,5 mikrogram/dosis
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
oxis turbuhaler 4,5 mikrogram/dosis inhalationspulver
2care4 aps - formoterolfumarat dihydrat - inhalationspulver - 4,5 mikrogram/dosis
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
oxis turbuhaler 9 mikrogram/dosis inhalationspulver
orifarm a/s - formoterolfumarat dihydrat - inhalationspulver - 9 mikrogram/dosis
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
oxis turbuhaler 9 mikrogram/dosis inhalationspulver
2care4 aps - formoterolfumarat dihydrat - inhalationspulver - 9 mikrogram/dosis
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
seroquel 300 mg depottabletter
orifarm a/s - quetiapin fumarat - depottabletter - 300 mg
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
seroquel 400 mg depottabletter
orifarm a/s - quetiapin fumarat - depottabletter - 400 mg
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
seroquel sr 200 mg depottabletter
orifarm a/s - quetiapin fumarat - depottabletter - 200 mg
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
seroquel sr 400 mg depottabletter
orifarm a/s - quetiapin fumarat - depottabletter - 400 mg
Unió Europea -
danès -
EMA (European Medicines Agency)
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, type 2 - narkotika anvendt i diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. - , trepersoners-kombinationsbehandling) som supplement til diæt og motion hos patienter, der ikke er tilstrækkeligt kontrolleret på deres maksimal tolereret dosis af metformin og et sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.